Elsevier

Annals of Oncology

Volume 31, Supplement 4, September 2020, Pages S552-S553
Annals of Oncology

699O Avelumab first-line (1L) maintenance + best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma (UC): Association between clinical outcomes and exploratory biomarkers

https://doi.org/10.1016/j.annonc.2020.08.771Get rights and content
Under an Elsevier user license
open archive

Cited by (0)